Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

260.39
BATS BZX Real-Time Price
As of 9:53am ET
 +2.86 / +1.11%
Today’s Change
106.00
Today|||52-Week Range
259.99
+81.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash164.1M916.1M600.3M322.6M
 
 
 
 
 
Short Term Investment Cash-230.2M752.0M-315.8M-277.7M
 
 
 
 
 
Cash & Short Term Investments170.4M916.1M600.3M322.6M
 
 
 
 
 
 
ReceivablesReceivables577.5M913.8M1.8B2.1B
 
 
 
 
 
 
InventoriesInventories355.2M531.3M883.0M950.6M
 
 
 
 
 
 
Current AssetsOther Current Assets254.3M416.3M587.8M844.1M
 
 
 
 
 
Current Assets1.4B2.8B3.9B4.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross540.0M636.2M2.1B2.3B
 
 
 
 
 
Depreciation-125.8M-173.5M-838.8M-977.9M
 
 
 
 
 
Intangible Assets11.3B14.5B22.6B20.6B
 
 
 
 
 
Other Assets11.3B14.6B22.8B20.8B
 
 
 
 
 
Total Assets13.1B18.0B28.0B26.4B
 
 
 
 
 
 
LiabilitiesAccounts Payable157.6M251.9M364.6M398.0M
 
 
 
 
 
Short Term Debt111.3M490.7M216.8M7.1M
 
 
 
 
 
Accrued Expenses361.6M131.5M227.4M258.7M
 
 
 
 
 
Other Current Liabilities573.1M956.5M1.6B2.0B
 
 
 
 
 
Other Liabilities924.3M1.8B2.5B2.7B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt6.5B10.5B17.2B15.3B
 
 
 
 
 
Deferred Taxes-1.1B-1.2B-2.3B-2.2B
 
 
 
 
 
Other Liabilities487.6M621.1M570.9M466.7M
 
 
 
 
 
Total Liabilities9.1B14.2B22.7B20.9B
 
 
 
 
 
 
EquityMinority Interest0.000.00-2.5M-1.3M
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity4.0B3.7B5.1B5.3B
 
 
 
 
 
Total Shareholder Equity4.0B3.7B5.1B5.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding306.4M303.9M333.0M334.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.